Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Keigo MAKINO"'
Autor:
Juntaro FUJITA, Nobuyuki HIROTSUNE, Yuki MATSUDA, Osamu HAMASAKI, Shoichi FUKUDA, Yoshihiro OKADA, Aiko KOBASHI, Shohei NISHIGAKI, Keigo MAKINO, Yusuke TOMITA, Naoya KIDANI, Kenichiro MURAOKA, Shigeki NISHINO
Publikováno v:
Neurologia Medico-Chirurgica, Vol 64, Iss 10, Pp 382-386 (2024)
Failure to retrieve a distal filter-based embolic protection device (EPD) is a potential complication of carotid artery stenting. This may be caused by trapping of the proximal marker of the EPD within the stent tip marker. Maintaining an adequate di
Externí odkaz:
https://doaj.org/article/1d307fe54ca3421ba91fee877513c1f9
Autor:
Makoto Ueno, Chigusa Morizane, Masayuki Furukawa, Daisuke Sakai, Yoshito Komatsu, Yousuke Nakai, Masahiro Tsuda, Masato Ozaka, Nobumasa Mizuno, Manabu Muto, Akira Fukutomi, Masafumi Ikeda, Akihito Tsuji, Akio Katanuma, Toshikazu Moriwaki, Takeshi Kajiwara, Hiroshi Ishii, Yuji Negoro, Satoshi Shimizu, Noriko Nemoto, Shingo Kobayashi, Keigo Makino, Junji Furuse
Publikováno v:
Cancer Medicine, Vol 10, Iss 6, Pp 2088-2099 (2021)
Abstract Purpose Effective second‐line chemotherapy options are limited in treating advanced biliary tract cancers (BTCs). Resminostat is an oral histone deacetylase inhibitor. Such inhibitors increase sensitivity to fluorouracil, the active form o
Externí odkaz:
https://doaj.org/article/e0445e9649c546018114eb63c08c8a74
Autor:
Atsuhito Uneda, Kazuhiko Kurozumi, Atsushi Fujimura, Kentaro Fujii, Joji Ishida, Yosuke Shimazu, Yoshihiro Otani, Yusuke Tomita, Yasuhiko Hattori, Yuji Matsumoto, Nobushige Tsuboi, Keigo Makino, Shuichiro Hirano, Atsunori Kamiya, Isao Date
Publikováno v:
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-23 (2021)
Abstract Glioblastoma (GBM) is the most lethal primary brain tumor characterized by significant cellular heterogeneity, namely tumor cells, including GBM stem-like cells (GSCs) and differentiated GBM cells (DGCs), and non-tumor cells such as endothel
Externí odkaz:
https://doaj.org/article/a0638dbbb3624887941a84049bd7896b
Autor:
Yuji Matsumoto, Tomotsugu Ichikawa, Kazuhiko Kurozumi, Yoshihiro Otani, Atsushi Fujimura, Kentaro Fujii, Yusuke Tomita, Yasuhiko Hattori, Atsuhito Uneda, Nobushige Tsuboi, Keisuke Kaneda, Keigo Makino, Isao Date
Publikováno v:
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-13 (2020)
Abstract Glioblastoma (GBM) is characterized by extensive tumor cell invasion, angiogenesis, and proliferation. We previously established subclones of GBM cells with distinct invasive phenotypes and identified annexin A2 (ANXA2) as an activator of an
Externí odkaz:
https://doaj.org/article/6c761b1949624b2696f149d55408b8a8
Autor:
Yasuhiko Hattori, Kazuhiko Kurozumi, Yoshihiro Otani, Atsuhito Uneda, Nobushige Tsuboi, Keigo Makino, Shuichiro Hirano, Kentaro Fujii, Yusuke Tomita, Tetsuo Oka, Yuji Matsumoto, Yosuke Shimazu, Hiroyuki Michiue, Hiromi Kumon, Isao Date
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0273242 (2022)
Reduced expression in immortalized cells/Dickkopf-3 (REIC/Dkk-3) is a tumor suppressor and its overexpression has been shown to exert anti-tumor effects as a therapeutic target gene in many human cancers. Recently, we demonstrated the anti-glioma eff
Externí odkaz:
https://doaj.org/article/60c3b1065683424a95b1b96535ea3c5a
Autor:
Yusuke Tomita, Shoichi Fukuda, Aiko Kobashi, Yoshihiro Okada, Keigo Makino, Naoya Kidani, Kenichiro Muraoka, Nobuyuki Hirotsune, Shigeki Nishino
Publikováno v:
Surgical Neurology International; 2024, Vol. 15, p1-4, 4p
Autor:
Yasuki Suruga, Kaishi Satomi, Yoshihiro Otani, Kentaro Fujii, Joji Ishida, Atsuhito Uneda, Nobushige Tsuboi, Keigo Makino, Shuichiro Hirano, Naoya Kemmotsu, Ryoji Imoto, Ryo Mizuta, Yusuke Tomita, Takao Yasuhara, Kana Washio, Hiroyuki Yanai, Yuko Matsushita, Yuko Hibiya, Akihiko Yoshida, David Capper, Koichi Ichimura, Isao Date
Publikováno v:
Journal of neuro-oncology. 160(1)
Pilocytic astrocytoma (PA) is a circumscribed low-grade astrocytic glioma, generally considered to be associated with a good prognosis. However, a subset of PA patients shows unfavorable outcomes. In this study, we retrospectively reviewed PA patient
Autor:
Keigo Makino, Hiroshi Ishii, Akihito Tsuji, Masato Ozaka, Makoto Ueno, Shingo Kobayashi, Manabu Muto, Daisuke Sakai, Yoshito Komatsu, Masafumi Ikeda, Nobumasa Mizuno, Akira Fukutomi, Toshikazu Moriwaki, Yousuke Nakai, Masayuki Furukawa, Takeshi Kajiwara, Akio Katanuma, Chigusa Morizane, Yuji Negoro, Masahiro Tsuda, Satoshi Shimizu, Junji Furuse, Noriko Nemoto
Publikováno v:
Cancer Medicine, Vol 10, Iss 6, Pp 2088-2099 (2021)
Cancer Medicine
Cancer Medicine
Purpose Effective second‐line chemotherapy options are limited in treating advanced biliary tract cancers (BTCs). Resminostat is an oral histone deacetylase inhibitor. Such inhibitors increase sensitivity to fluorouracil, the active form of S‐1.
Autor:
Nobushige Tsuboi, Kazuki Kobayashi, Noriyuki Nagayama, Hideyuki Yoshida, Yuu Takahashi, Ryu Kimura, Tadato Yukiue, Takao Yasuhara, Susumu Sasada, Ryo Mizuta, Tomoyuki Ogawa, Isao Date, Keigo Makino
Publikováno v:
Neurologia medico-chirurgica
We developed a new cranioplasty method that utilizes artificial bone made of ultra-high-molecular-weight polyethylene, with a wedge-shaped edge (UHMWPE Wing). This study shows the methods and data of case series and finite element analyses with the U
Autor:
Nobushige Tsuboi, Atsunori Kamiya, Kentaro Fujii, Yoshihiro Otani, Yusuke Tomita, Atsushi Fujimura, Yuji Matsumoto, Joji Ishida, Yasuhiko Hattori, Kazuhiko Kurozumi, Shuichiro Hirano, Yosuke Shimazu, Isao Date, Keigo Makino, Atsuhito Uneda
Publikováno v:
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-23 (2021)
Acta Neuropathologica Communications
Acta Neuropathologica Communications
Glioblastoma (GBM) is the most lethal primary brain tumor characterized by significant cellular heterogeneity, namely tumor cells, including GBM stem-like cells (GSCs) and differentiated GBM cells (DGCs), and non-tumor cells such as endothelial cells